331 results about "Nasal passage" patented technology

A mask system for use between a patient and a device to deliver a breathable gas to the patient includes a mouth cushion, a pair of nasal prongs, an elbow, and a headgear assembly. The mouth cushion is structured to sealingly engage around an exterior of a patient's mouth in use, and the pair of nasal prongs are structured to sealingly communicate with nasal passages of a patient's nose in use. The elbow delivers breathable gas to the patient. The headgear assembly maintains the mouth cushion and the nasal prongs in a desired position on the patient's face. The headgear assembly provides a substantially round crown strap that cups the parietal bone and occipital bone of the patient's head in use.

A method for dilating a Eustachian tube of a patient is disclosed. In one embodiment, the method may involve advancing a dilation device through a nasal passage of the patient to position a dilator of the device at least partially in a Eustachian tube of the patient, expanding the dilator to an expanded configuration to dilate a portion of the Eustachian tube, collapsing the dilator, and removing the dilation device from the patient. The dilated portion of the Eustachian tube remains at least partially dilated after removal of the device.

A breathing arrangement includes a patient interface, at least one inlet conduit, and a headgear assembly. The patient interface includes a mouth covering assembly including a cushion structured to sealingly engage around exterior of a patient's mouth in use, a nozzle assembly including a pair of nozzles structured to sealingly engage within nasal passages of a patient's nose in use, and an element connecting the mouth covering assembly and the nozzle assembly. The at least one inlet conduit is structured to deliver breathable gas into at least one of the mouth covering assembly and the nozzle assembly for breathing by the patient. The headgear assembly is removably connected to at least one of the mouth covering assembly and the nozzle assembly so as to maintain the mouth covering assembly and the nozzle assembly in a desired position on the patient's face.

Methods and systems for accessing a Eustachian tube of a patient are disclosed. The system includes a guide configured for passing into a nasal passage of the patient to position a distal tip of the catheter at or near a Eustachian tube, the guide having a distal tip with a bend having an angle between 30 and 90 degrees; and a guidewire configured to pass through the guide into the Eustachian tube. A device for providing therapy to the Eustachian tube is passed through the guide.

A face mask for ventilation of a patient. A face piece is disposed on the patient's face. An oral tube and a nasal tube are disposed through corresponding ports in the face piece. The oral tube extends through the mouth of the patient and the nasal tube extends through the nasal passage of the patient. The ends of the oral tube and the nasal tube are received in the posterior oropharynx of the patient. An adapter is connected to the ends of the oral tube and the nasal tube exteriorly of the face piece. Oxygen is introduced into an inlet port of the adapter wherein the oxygen enters the oral tube and the nasal tube concomitantly and ventilates the patient.

Method and systems for accessing a Eustachian tube of a patient are disclosed. The system includes a guide configured for passing into a nasal passage of the patient to position a distal tip of the catheter at or near a Eustachian tube, the guide having distal tip with a bend having an angle between 30 and 90 degrees; and a guidewire configured to pass through the guide into the Eustachian tube.

The present invention comprises a nasal cannula (2), shaped to fit within a user's nares, where the nasal cannula includes at least one prong (24, 25) allowing high flow delivery of humidified gases and creates positive airway pressure in the patient's airway. The prongs have angled ends (31, 32), such that in use, gases flowing through the prongs are directed to the user's nasal passages. The nasal cannula body is partially swivelling and preferably has a ball joint connector (37, 39). In another embodiment the nasal cannula may have at least one flared end prong (31, 32) that preferably seals within a patient's nare.

A nasal prong for sealing with a nasal passage of a patient includes a head portion structured to seal and/or sealingly communicate with the patient's nasal passage and a column or stalk structured to interconnect the head portion with a base. The nasal prong is structured to redirect air flow direction, diffuse air flow or create turbulence, and/or orient a prong orifice in order to reduce and/or eliminate air jetting effects.

A device and method for dilating a Eustachian tube of a patient is disclosed. The device includes a guide catheter and a balloon dilation catheter. The balloon dilation catheter has an actuator that prevents injury to the middle ear. The balloon dilation catheter is slidably coupled with the guide catheter through the guide catheter lumen and is fully inserted into the guide catheter lumen when the distal side of the actuator is adjacent to the proximal end of the guide catheter. The method involves advancing the guide catheter and balloon dilation catheter through a nasal passage of the patient to dilate a portion of the Eustachian tube.

A nasal dilator that prevents the outer wall tissue of the nasal passages of the nose from drawing in during breathing includes a flexible strip of material having a first end region, a second end region and an intermediate segment. The dilator further includes first and second resilient bands secured to one surface of the strip the first and second end regions, and a third resilient band secured to a second surface of the flexible strip adjacent the intermediate segment. The ends of the third resilient band overlie the inward ends of the first and second resilient bands whereby the third resilient band extends over and at least partly beyond the bridge on both sides of the bridge of the nose. A first adhesive surface covers the first surface of the strip of material so that there is a perimeter of space formed around and between the first and second resilient bands which are inset centrally on the strip. Adhesive or auxiliary supports can be used to secure the ends of the third band to the second surface of the strip.

A multi-chamber mask includes a shell and a partition. The shell is adapted to cover portions of a user's face including the mouth and at least portions of the nose including the nostrils, the shell adapted to contact the face surrounding the covered portions of the face to substantially prevent gas from escaping between the shell and the contacted portions of the user's face, and the shell is adapted to couple to a gas supply source. The partition is coupled to the shell and cooperates with the shell to define a first chamber and a second chamber, the first chamber adapted to be positioned proximate the user's nose to direct inflow of gas from the gas supply source to the user's nasal passages, the second chamber adapted to be positioned proximate the user's mouth, the partition adapted to restrict flow of gas between the first and the second chamber.

The present invention relates to the delivery of high flow humidified pressurised oxygen and/or air to a patient by way of a wide bore nasal cannula (30). The cannula of the present invention comprises wide bore cannula to minimise the flow resistance and the entry velocity. The nasal cannula includes two nasal prongs (40, 41) fittable into a patient's nostrils. The prongs follow the inner shape of the patient's nostrils such that a more efficient flow of gases into the patient's lungs is achieved as gases flow are directed down the main nasal passage more accurately. The cannula do not seal within the nasal cavities of the patient, and in some embodiments the cannula may be provided with a pressure relief valve to allow gases to be exhausted from the cannula.

Mouthpiece (1) having vestibular shield (21) overlapping a user's teeth and gums, gases passageway means extending through said vestibular shield allowing for the passage of said gases through mouthpiece and extra oral sealing (25) means associated with gases passageway, said passageway in use causes gases to be diffused (outlets 23, 24) when exiting from gases passageway. Mouth piece may have a noseflap to seal the user's nose or provide a passageway for use'r s nasal passages. Mouthpiece may have adjustment means to alter distance between said vestibular shield and said extra-oral sealing means.

The invention relates generally to methods and apparatus for inducing hypothermia in an animal. Known methods for inducing hypothermia all involve cooling the outside or inside of an animal, sometimes in conjuction with drugs that disable the animal's homeostatic responses. The present invention is directed to a method and apparatus for applying heat to the hypothalamus of a warm-blooded animal in order to utilize the physiological mechanisms that regulate body temperature to effect a compensatory cooling response, thereby lowering body temperature. It is new and unsuggested in the art to apply heat in an effort to reduce body temperature. The invention effects the desired lowering of body temperature by the method od raising the temperature of the hypothalamus, a brain structure situated in humans just above the pituitary gland responsible for temperature regulation, by warming a nasal passage, or a sinus, such as the sphenoid sinus that is nearest to the hypothalamus, or by direct warming of the hypothalamus, or a combination of these.

Disclosed is an introducer apparatus comprising an sleeve fixation mechanism or introducer member, such as a catheter, introducer, or ring-like structure, which is attached to a protective sleeve comprising a thin flexible material such a polymeric film. The sleeve is inverted into the passageway of a second member, such as a catheter, feeding tube, introducer, etc., that is advanced through the passageway of the introducer member and is introduced into a bodily passage of a patient, such as the bile duct, nasal passages, colon, etc. The sleeve everts from the passageway of the second member during its advancement to lay down a friction-reducing surface. The sleeve prevents frictional contact between the second member and delicate or sensitive tissues.

A nasal dilator comprises a laminate of vertically stacked layers forming a unitary, or single body, truss where each layer includes at least one member. The truss features horizontal regions adapted to engage outer wall tissues of first and second nasal passages and to traverse the bridge of a nose therebetween. When in use the dilator acts to stabilize and/or expand the nasal outer wall tissues and prevent said tissues from drawing inward during breathing. Manufacturing methods produce dilator layers and/or finished nasal dilator devices efficiently at the same or lower cost as traditional methods by fabricating dilator elements in whole or part along common lines or edges. Said common lines define peripheral dimensions and form spaced apart relationships between dilator layers, members and finished dilator devices without sacrificing usable material to do so. Manufacturing steps include cutting through a fabrication laminate along lines defining at least portions of one or more layers, members, and the truss's peripheral edges. Manufacturing methods further maximize material usage by incorporating waste material into a subsequent fabrication process. Dilator embodiments further include means for providing disparate dilating force to opposing nasal passages, and means for incorporating promotional printing into the dilator fabrication process.

A device, method and system for facilitating treatment of a sinusitis condition, including a heat source configured to deliver an output of heated air to the nasal passages of an individual, and a delivery component having a space through which the heated air output of the heat source may pass, the delivery component being configured for placement in the individual's nostrils. The system provides a heated air output source and one or more delivery components configured and sized to fit within the nostril of an individual, which may be used to deliver one or more courses of heated air to a user's sinuses through a nostril.

The present invention relates generally to the field of treatments for nasal congestion, and in particular, to a method and apparatus for alleviating nasal congestion in a patient by mechanically stimulating the sneezing reflex in the patient to urge drainage of the nasal passageways. The method includes inserting an instrument having a work tip portion provided with at least one filament into the nostril of the patient. The nasal mucosa of the patient is then probed with the at least one filament to stimulate in the patient the sneeze reflex. This probing action causes the patient to sneeze. With the patient's mouth closed, the sneeze urges at least one of mucus, fluid and debris in the nasal passages of the patient to be forcibly expelled through the nostrils of the patient thereby draining the nasal cavity of the patient. The instrument used in the performance of this method includes a handle portion upon which the work tip portion is carried. The handle portion may be integrally formed with the work tip portion or releasably attachable thereto. The instrument is further provided with a physical stop associated with one of the work tip portion and the handle portion to prevent injury resulting from the working tip portion being inserted too deeply into the nasal passages of the patient.

The apparatus includes a cylinder for containing a pressurized therapeutic oxygen gas, a nasal cannula, adapted to be introduced into a nasal passage of a patient, and a conduit extending between the cylinder and the nasal cannula for directing the therapeutic oxygen gas to the nasal cannula from the cylinder. A pressure sensor is provided on the conduit for detecting the pressure in the conduit. A valve is provided, in the conduit, which allows and blocks the fluid communication between the cylinder and the nasal cannula. A controller controls the operation of the valve in synchronization with the respiration of a patient, based on the changes in the pressure detected by the pressure sensor. The volume of the oxygen therapeutic gas passing through the valve for each respiration is increased, compared with a normal respiration condition, when the respiratory frequency increases.

Intranasal delivery devices include dosage forms containing medical compositions for use in the intranasal devices, and methods of delivering medical compositions to the nasal mucosa of users. The devices dispense a predetermined quantity of fluid into the nasal passage of a user, in which the predetermined quantity of fluid is contained in, or produced in a dosage form or blister that is crushed by a plunger with sufficient force to drive the dosage form against a piercing mechanism, piercing the dosage form and forcing the liquid contents from the dosage form and through a delivery channel into a spray to be directed into the nasal passage of a user. The plunger is connected to a trigger device by a linkage that confers a mechanical advantage to the trigger mechanism.

A novel telehealth video conferencing system (process) that is designed to enable the patient user to have a real-time or near real-time 2 way tele-conference/consult including the transfer of patient specific biometric information with a health care provider team (one or more health care providers simultaneously, i.e. a team consisting of a pharmacist, physician, mental health provider, clinical lab, mental health provider, orthopedist, podiatrist, dentist, clinical specialist, etc. . . . ) located remotely from the telehealth digital/video patient user portal. The present invention, the IPWP is an interactive-digital health care provider network to patient portal designed to provide patients with the same level of quality care that they would expect to receive if they were physically in a multispecialty doctor or health care providers' (nurse practitioner, physician assistant, dentist, ophthalmologist, orthopedist, podiatrist, medical specialty clinic, hospital, etc. . . . ) office. However, the patients that utilize the IPWP will interact with their health care provider/s on a computer/notebook/smart device screen/monitor via existing secure digital web or cellular camera technology in a mobile or stationary, enclosed/private HIPP compliant environment at a retail pharmacy or a pharmacy supported location (workplace, educational facilities, retail stores, etc. . . . that have an in-house, adjacent or an electronic dispensing pharmacy). Current statistics demonstrate that 80% of primary care provider visits result in the health care provider writing a script for medication. Medication management is critical to safe, effective quality care and has been an issue of health care reforms Accountable Care Organization concept since 2009. In order for the patient to receive comparable care to what they would receive in a multispecialty provider/doctor's office with an onsite pharmacy, the IMP will combine the use of existing biometric sensor technologies (i.e. Strain Gauge Tech, IR Thermometer, etc.) in order for the system to take patient real time biometric information such as height, weight, blood pressure, pulse, EKG, blood glucose, body temperature, etc. . . . as well as identify the patient positively by both video capture and biometric scanning (fingerprint, iris scan, driver's license photo, etc. . . . ). It also has the capability to upload information from certain glucose readers in order for the physician to better assess a patient's blood sugar levels and may incorporate the use of magnified micro camera technology and lighting to look at a patient's microanatomy (ear canals, nasal passages, skin conditions, color and eye examination, etc. . . . ). In addition to the use of sensor technology the IPWP can incorporate the use of antimicrobial materials or technologies (copper ions, silver ions, UV light, HEPA filters, etc. . . . ) to reduce the communication of disease from patient to patient. The monitor, web camera, and other vital components will be designed to be permanently or temporarily (mobile system) located within a secure/private enclosure at a pharmacy or pharmacy supported location (private kiosk, room, booth, enclosure, space, etc. . . . ). All patient information and electronic forms will be transmitted via a secure encrypted web based digital or cellular portal to multiple providers as needed simultaneously for a seamless 3-way (or more) consultation/communication. The IPWP will be linked to a smartphone/computer/Internet/web app that will allow the patient to view availability and schedule appointments at their local pharmacies IPWP or alternatively on a walk-in, as needed basis. Lastly, the unit will be equipped with electronic payment technologies such as card (swipe) readers, etc. . . . to capture/collect payment from credit cards, PayPal and debit cards for all health care services provided including, but limited to co-pays, payments, prescriptions, lab test, etc. . . . .

In summary the ability of the patient portal system to provide real time, multiple simultaneously communicating health care providers with real time biometric information (including the onsite or tele pharmacist) is a novel process not limited to the single provider video/audio access currently patented. This new dimension to telehealth promises a telehealth experience that at a minimum matches the diagnostics ability and access of a multispecialty clinic or traditional hospital setting while exceeding the clinical/diagnostic ability of a single health care provider's office or clinic that is more accessible at a 50% reduced cost and resulting in better health outcomes.